Neutrogin


Combined with:

Alkeran
Maxipime

Indications and Reactions:

Role Indications Reactions
Secondary
Product Used For Unknown Indication 19.6%
Fluid Replacement 8.7%
Sedation 8.6%
Infection 7.1%
Prophylaxis 7.0%
Ureteral Stent Insertion 7.0%
Ureteral Stent Removal 7.0%
Breast Cancer 4.4%
Diuretic Therapy 4.3%
Pyrexia 3.1%
Infection Prophylaxis 3.1%
Insomnia 2.9%
Anticoagulant Therapy 2.8%
Prophylaxis Against Graft Versus Host Disease 2.8%
Neutropenia 2.4%
Electrolyte Substitution Therapy 2.3%
Febrile Neutropenia 2.1%
Drug Use For Unknown Indication 1.7%
Neutrophil Count Decreased 1.6%
Hypertension 1.6%
Respiratory Failure 21.6%
Interstitial Lung Disease 17.5%
Vertigo 6.2%
Viral Infection 6.2%
White Blood Cell Count Decreased 5.2%
Arthralgia 4.1%
Blood Lactate Dehydrogenase Increased 4.1%
Bronchitis 4.1%
Dyspnoea 4.1%
Drug Eruption 3.1%
Pyrexia 3.1%
Renal Failure 3.1%
Rhabdomyolysis 3.1%
White Blood Cell Count Increased 3.1%
Acute Lung Injury 2.1%
Granulocytopenia 2.1%
Histiocytosis Haematophagic 2.1%
Rash 2.1%
Stomatitis 2.1%
Acute Respiratory Distress Syndrome 1.0%
Concomitant
Product Used For Unknown Indication 18.7%
Prophylaxis 15.9%
Drug Use For Unknown Indication 10.6%
Infection Prophylaxis 6.1%
Stem Cell Transplant 5.9%
Hiv Infection 5.4%
Ovarian Cancer Recurrent 4.9%
Prophylaxis Against Gastrointestinal Ulcer 3.6%
Cancer Pain 3.0%
Encephalitis Cytomegalovirus 2.7%
Allogenic Bone Marrow Transplantation Therapy 2.7%
Immunosuppression 2.7%
Acute Lymphocytic Leukaemia 2.6%
Febrile Neutropenia 2.5%
Multiple Myeloma 2.4%
Pyrexia 2.4%
Antifungal Prophylaxis 2.2%
Insomnia 2.0%
Aplastic Anaemia 1.9%
Neoplasm Malignant 1.9%
White Blood Cell Count Decreased 27.7%
Sepsis 8.8%
Shock 8.7%
Pneumonia 8.5%
Pancytopenia 6.2%
Pyrexia 5.4%
Febrile Neutropenia 4.4%
Thrombocytopenia 4.4%
Septic Shock 3.7%
Renal Disorder 3.3%
Renal Impairment 2.7%
Vomiting 2.7%
Venoocclusive Liver Disease 2.1%
Myelodysplastic Syndrome 1.7%
Rash 1.7%
Respiratory Failure 1.7%
White Blood Cell Disorder 1.7%
Diarrhoea 1.5%
Renal Failure Acute 1.5%
Staphylococcal Sepsis 1.5%

Drug Data